MSB-0010445

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameMSB-0010445
Drug Alias NameSelectikineMSB-0010445NHS-IL2EMD-521873NHS-IL2-LT
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionDNA inhibitorsInterleukin-2 receptor agonists
TargetsInterleukin-2 receptorDNA
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEmd Serono IncMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmd Serono IncMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A